Back to Results
First PageMeta Content
Pharmaceutical sciences / Food and Drug Administration / Validity / Food safety / Pharmacology / Limulus amebocyte lysate / United States Pharmacopeia / Medical device / Endotoxin / Medicine / Pharmaceutical industry / Health


Withdrawal of FDA Guideline Michael Dawson, Ph.D., RAC July, 2011 LALUpdate
Add to Reading List

Document Date: 2011-09-14 09:38:44

Open Document

File Size: 265,64 KB

Share Result on Facebook

City

Strasbourg / Rockville / Liverpool / Walldorf / Arlington / East Falmouth / /

Company

Cape Cod Inc. / UK Office Associates / Office PYROQUANT DIAGNOSTIK GmbH / compe- Corporate Headquarters Associates / Corporate Headquarters Associates / European Office Pyroquant Diagnostik GmbH / /

Continent

Europe / /

Country

Germany / France / United Kingdom / /

Event

Product Issues / Product Recall / /

IndustryTerm

pooled extract solution / drugs products / chemical composition / portable test systems / online version / intrathecal devices / to medical devices / manufacturing procedures / /

Organization

FDA Center for Biologics Evaluation and Research / Association for the Advancement of Medical Instrumentation / FDA Center for Devices and Radiological Health / FDA / European Pharmacopoeia Commission / European Union / /

Person

Michael Dawson / /

Position

author / Editor / analyst / General / /

Product

Corporate Headquarters Associates of Cape Cod / INTERFERENCE TESTING / CONCLUSION / guidance documents / /

ProvinceOrState

Virginia / Maryland / Massachusetts / /

URL

http /

SocialTag